IL-39: A Potential Drug Target (P42538)

Target Name: Interleukin-39 (IL-39)

NCBI ID: P42538

Interleukin-39 (IL-39)

Other Name(s): IL-23p19/Ebi3

IL-39: A Potential Drug Target

Interleukin-39 (IL-39) is a cytokine that plays a crucial role in the regulation of immune responses and tissue homeostasis. It is a member of the interleukin family, which includes IL-1, IL-2, IL-3, and IL-4, and is expressed in a variety of tissues throughout the body. IL-39 is a 19-kDa protein that is expressed in tissues such as the skin, hair, and nails, and is involved in the regulation of cell proliferation, differentiation, and survival.

The IL-39 pathway is a complex signaling pathway that is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. It is a highly conserved pathway that is involved in the regulation of a wide range of cellular processes, including immune responses, tissue homeostasis, and cell survival. The IL-39 pathway is characterized by the presence of several key signaling molecules, including IL-3, IL-6, and PD-1.

IL-3 is a key signaling molecule in the IL-39 pathway. It is a cytokine that is produced by various cell types in response to the presence of infection or injury. IL-3 is involved in the regulation of cellular processes such as cell growth, differentiation, and survival, and is a potent motivator for immune responses.

PD-1 is another key signaling molecule in the IL-39 pathway. It is a transmembrane protein that is involved in the regulation of T cell function. PD-1 is activated by the presence of an agonist, which causes it to interact with its Ligand PD-L1. The interaction between PD-1 and PD-L1 is critical for the regulation of T cell responses, and is a key factor in the development of cancer.

IL-39 is a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It is a potent motivator for immune responses and is involved in the regulation of a wide range of cellular processes. As a As a result, IL-39 is a potential drug target and may be useful in the treatment of a variety of diseases.

IL-39 is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. It is a potent motivator for immune responses and is involved in the regulation of a wide range of cellular processes. As a result, IL-39 is a potential drug target and may be useful in the treatment of a variety of diseases.

In conclusion, IL-39 is a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It is a potent motivator for immune responses and is involved in the regulation of a wide range of cellular processes . As a result, IL-39 is a potential drug target and may be useful in the treatment of a variety of diseases. Further research is needed to fully understand the role of IL-39 in cellular processes and its potential as a drug target.

Protein Name: Interleukin-39 (IL-39)

The "Interleukin-39 (IL-39) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interleukin-39 (IL-39) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets